You are here

  • Home
  • Archive
  • Volume 45, Issue 2
  • SCN5A R1193Q polymorphism associated with progressive cardiac conduction defects and long QT syndrome in a Chinese family

Article Text

Article menu
Download PDFPDF
Correspondence
PostScript
SCN5A R1193Q polymorphism associated with progressive cardiac conduction defects and long QT syndrome in a Chinese family
  1. A Sun1,
  2. L Xu1,
  3. S Wang1,
  4. K Wang1,
  5. W Huang2,
  6. Y Wang2,
  7. Y Zou3,
  8. J Ge3
  1. 1
    Shanghai Institute of Cardiovascular Diseases, and Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China
  2. 2
    Chinese National Human Genome Center at Shanghai, Shanghai, China
  3. 3
    Shanghai Institute of Cardiovascular Diseases, and Department of Cardiology, Zhongshan Hospital, and Institutes of Biomedical Sciences, Fudan University, Shanghai, China
  1. Dr A Sun, Shanghai Institute of Cardiovascular Diseases, and Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China; ajsun{at}zshospital.net

https://doi.org/10.1136/jmg.2007.056333

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Previous studies have demonstrated that the prevalence rate of R1193Q in SCN5A gene ranges from 0.2–12% and suggested this mutation may be a risk factor for long QT syndrome (LQTS).1 2 However, Chen et al showed no association between R1193Q and the disease process or electrocardiographic (ECG) abnormalities in a four generation Chinese family with cardiac conduction abnormalities and sudden death.1

    We recently identified the R1193Q polymorphism by direct DNA sequencing of SCN5A in a four generation Han Chinese pedigree with progressive cardiac conduction defect (PCCD) and LQTS. Out of the seven R1193Q carriers, five (III-7, III-10, III-12, III-13, IV-5) were diagnosed as PCCD, and two (III-10, III-12) also had prolonged QTc; one carrier (III-1) had no PCCD but with borderline prolonged QTc; only the …

    View Full Text

    Footnotes

    • Competing interests: None declared.

    • Patient consent: Informed consent was obtained for the publication of the family’s details in this report.